Genetic testing plan for patients with unclear disease cause
Part of Genetic & congenital clinical trials.
This study helps decide treatment planning based on genetic testing for people whose disease cause is unclear but may be genetic. It’s meant to support a “genomic health” approach, where results guide next steps in care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your disease has an unclear molecular cause (doctors can’t explain it yet based on available tests)
- Your doctors suspect a genetic (inherited or DNA-related) cause
- You and, if needed, your legal representative can give informed consent to join
- You have not already had whole-exome sequencing (WES)
- You have not already had a genetic panel test (a targeted DNA test)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well different genetic tests (whole exome/genome sequencing and standard genetic tests) work for diagnosing rare genetic diseases and inherited cancer conditions. It may help confirm which testing approach provides the clearest results for families.
This study aims to use advanced genetic testing to better understand rare and genetic diseases. It may help find a diagnosis or guide personalized care for you or your child.
This study looks for a genetic (DNA) explanation for rare diseases when usual genetic testing hasn’t found an answer. It may help by re-analyzing prior results and comparing them with parents’ DNA to better pinpoint the cause.
This study uses a new, advanced DNA sequencing method (long-read sequencing) to try to clarify unclear or incomplete genetic test results. If you or a family member have had genetic testing that left unanswered questions, this trial may help find more definite answers.
This study evaluates people whose medical cause is still unclear even after genetic tests and other workups. It uses coded health data and lab samples to look for a new or rare genetic cause, and it may return additional (“secondary”) genetic findings.
This study uses a new, advanced method of reading your DNA (called long-read sequencing) to find the genetic cause of a condition that has not been explained by other tests. It may help you and your doctor understand what is causing your health problem.
Hear when a new Rare Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.